Advanced/Metastasis Renal Cell Carcinoma

1 clinical trials · Condition

Record	Firm	Date
A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC Patients (NCT01831973)	Taiwan Liposome Company	2012-11-30

Every clearance here is in the API, with alerts when new ones post.